NCT05037032View on ClinicalTrials.gov

Effects of Naltrexone on Nocturnal Breathing Patterns at Altitude

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 8, 2021

Primary Completion Date

October 17, 2021

Study Completion Date

October 17, 2021

Conditions
AltitudeSleep Apnea, Central
Interventions
DRUG

Naltrexone Pill

50 mg PO one-time only

DRUG

Placebo

Matching placebo for naltrexone

Trial Locations (1)

92357

VA Loma Linda Healthcare System, Loma Linda

All Listed Sponsors
lead

VA Loma Linda Health Care System

FED

NCT05037032 - Effects of Naltrexone on Nocturnal Breathing Patterns at Altitude | Biotech Hunter | Biotech Hunter